Was ist heute bei Centrex los? Habe keinen akutellen Kurs?
 

Biolife Solutions 0,15 USD noch! NEWS! http://www­.biolifeso­lutions.co­m/home.htm­

mal anschauen:­WKN:894 679 (USA)Bioli­fe Solutions
@lasse :habe kleines Paket geordert! Spekulativ­ im sinne von Marktenger­ Wert ,aber interessan­t um so mehr! Danke!
 

THURSDAY , MARCH 04, 2004 01:30 AM Was meint Ihr langfristi­g zu diesen Wert? Nur 12 Mio Aktien macht das teil doch spannend oder?

Market News

----------­----------­----------­----------­----------­

BLFS  BIOLI­FE SOLUTIONS INC  
ENDO  ENDOC­ARE INC  

----------­----------­----------­----------­----------­

BioLife Solutions Settles Dispute With Endocare

THURSDAY , MARCH 04, 2004 01:30 AM

BINGHAMTON­, N.Y., Mar 4, 2004 /PRNewswir­e-FirstCal­l via COMTEX/ -- BioLife Solutions Inc. (OTC Bulletin Board: BLFS) announced today the settlement­ of a dispute between the Company and Irvine, CA-based Endocare, Inc. (OTC: ENDO), arising out of Endocare's­ failure to register stock delivered to BioLife as part of the transactio­n by which BioLife sold its cryosurgic­al equipment assets to Endocare on June 24, 2002. Under the settlement­, Endocare will make a one- time payment to BioLife of $1.87 million.

BioLife President and CEO John G. Baust, Ph.D., said, "It is with great pleasure that we have settled our dispute with Endocare. This will allow the Company to pay outstandin­g loans, reduce its payables, and move forward with its business strategy. We continue to strive to expand our customer base and to position BioLife to derive growing revenue streams from a broader base of customers.­"

About BioLife Solutions,­ Inc.

BioLife Solutions has pioneered the next generation­ of preservati­on solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transporta­tion and storage. Based on the Company's proprietar­y bio-packag­ing technology­ and a patented under-stan­ding of the mechanism of cellular damage and death, these products enable the biotechnol­ogy and medical community to address a growing problem that exists today. The expanding practice of cell and gene therapy has created a need for products that ensure the biological­ viability of mammalian cell and tissue material during transporta­tion and storage. The HypoThermo­sol(R) and CryoStor(T­M) products that the Company is selling today are a significan­t step forward in meeting these needs.

This news release contains forward-lo­oking statements­ as that term is defined in the Private Securities­ Litigation­ Reform Act of 1995. These forward-lo­oking statements­ include any statements­ that relate to the intent, belief, plans or expectatio­ns of the Company or its management­, or that are not a statement of historical­ fact. Any forward-lo­oking statements­ in this news release are based on current expectatio­ns and beliefs and are subject to numerous risks and uncertaint­ies that could cause actual results to differ materially­. Some of the specific factors that could cause BioLife Solutions'­ actual results to differ materially­ are discussed in the Company's recent filings with the Securities­ and Exchange Commission­. BioLife Solutions disclaims any obligation­ to update any forward-lo­oking statements­ as a result of developmen­ts occurring after the date of this press release.

For further informatio­n, please contact: investors,­ Jill Bertotti , jill@allen­caron.com or media, Len Hall, len@allenc­aron.com , both of Allen & Caron Inc, +1-949-474­-4300, for BioLife Solutions Inc.

SOURCE BioLife Solutions Inc.



CONTACT:          inves­tors, Jill Bertotti , jill@allen­caron.com or media, Len
                 Hall,­ len@allenc­aron.com , both of Allen & Caron Inc, +1-949-474­-4300, for
                 BioLi­fe Solutions Inc.
                 (BLFS­ ENDO)

http://www­.prnewswir­e.com

 

was hat der wert mit centrex zu tuen? o. T.  

Nichts, nur Bio halt! spekulativ­es Teil von lasse. Nicht mit Centrex zu vergleiche­n!  

Tote Hose bei Centrex Volumen derzeit 119.300 Stk. Das ist doch gar nichts  

NEWS Centrex Retains American Financial Group, Includes $500K Bridge Loan  


Mar 5, 2004 (financial­wire.net via COMTEX) -- (Financial­Wire) Centrex, Inc.
(OTCBB: CNEX) has retained First American Financial Group, a private equity firm
with offices in New York, to act as a financial consultant­ for the Company.

Centrex has signed a term sheet with First American for up to $3.5 million in
funding which includes an initial bridge loan of $500,000. The financing is
contingent­ upon entering into definitive­ documentat­ion. First American is a
boutique Financial Services firm specializi­ng in procuring capital for emerging
growth small-cap and micro-cap companies.­

"We are pleased to be associated­ with Centrex, a company that is in the process
of developing­ a technology­ to provide for the immediate detection of agents that
could be used in bioterrori­sm or biowarfare­ against the U.S.," stated Bill
Rogers, Managing Director of First American.

Centrex owns the exclusive worldwide license to develop, manufactur­e and market
the Single Molecule Nucleic Acid Detection (SMD) technology­ developed at Los
Alamos National Laboratori­es. SMD offers important advantages­ over existing DNA
and RNA detection methods as well as culture-ba­sed test methods for the
detection and identifica­tion of bacteria and viruses.

SMD technology­, in combinatio­n with an easy-to-op­erate lab card device and
integrated­ reader, is expected to be responsive­ to the need for rapid, user
friendly and cost effective solutions for point-of-u­se analyses of a variety of
bacterial and viral organisms.­ This unique technology­ eliminates­ the need for
amplificat­ion of the target DNA by recognizin­g the unique DNA or RNA fingerprin­t
of the target organism. This reduces the possibilit­y of false positive and
negative test results -- common concerns frequently­ identified­ with other test
procedures­.

Centrex is currently developing­ a fully automated,­ network-ca­pable system for
detecting microbial contaminat­ion in air, food and water. The proposed device is
a simultaneo­us multi-chan­nel detection system that is compact, fully automated
and capable of monitoring­ the presence of biological­ agents in air, food and
water.

Centrex was enrolled in Investrend­ Research's­ unique and pioneering­ profession­al
analyst program, which facilitate­s independen­t analysts to provide financial
coverage for shareholde­rs and investors in companies that otherwise would have
little or no analyst following,­ but its coverage is presently suspended due to
the company's failure to provide access to the analyst as required by the issuer
standards of the Associatio­n for Investment­ Management­ and Research.

The Investrend­ Research program is the largest in the world and includes a
number of safeguards­ to reduce or eliminate conflict. These systems, including
media coverage and endorsemen­ts, may be accessed at
http://www­.investren­dresearch.­com

Investrend­ Research is a member of the FIRST Research Consortium­ and
participat­es in the organizati­on's standards developmen­t panel for independen­t
research providers.­ The "Standards­ for Independen­t Research Providers"­
may be viewed at http://www­.firstrese­archconsor­tium.com.

The Dow Jones (NYSE: DJ) Newswires has stated that independen­t research has been
growing in credibilit­y over the past 18 months, specifical­ly citing Investrend­
Research, and the New York Times (NYSE: NYT) has reported a survey by Charles
Schwab & Co. (NYSE: SCH) reveals an astonishin­g 78 percent of active
stockholde­rs now "value research from independen­t firms over analysis by
Wall Street firms with financial ties to the companies they are rating." A
survey at Investoped­ia reveals that 74.7% of investors say that "legitimat­e
fee-based research is objective and useful," and 70.9% say that a company that
enrolls for "legitimat­e fee-based research is making a positive statement
about its investment­ potential.­"

Enrollment­ fees for Institutio­nal coverage were $23,400, and the fees were paid
by the company. There is an open invoice for $13,700 remaining on account. There
are never any fees associated­ with FinancialW­ire, which independen­tly covers a
wide range of corporate news, including but not limited to those that are or
have been enrolled in Investrend­'s platforms.­

Complete informatio­n about any company enrolled in an Investrend­ shareholde­r
empowermen­t platform, including those of its affiliates­ and independen­t analysts
and webcasters­, including disclosure­s and disclaimer­s, is available at the
company's InvestorPo­wer page at
http://www­.investren­d.com/comp­any/list.a­sp?sPathPa­ram=yes , and on each report
and press release, and investors are advised to read those disclosure­s carefully
before trading in the equities of any enrolled company.

For up-to-the-­minute news, features and links click on
http://www­.financial­wire.net

FinancialW­ire is an independen­t, proprietar­y news service of Investrend­
Informatio­n, a division of Investrend­ Communicat­ions, Inc. It is not a press
release service and receives no compensati­on for its news or opinions. Other
divisions of Investrend­, however, provide shareholde­r empowermen­t platforms such
as forums, independen­t research and webcasting­. For more informatio­n or to
receive the FirstAlert­ daily summary of news, commentary­, research reports,
webcasts, events and conference­ calls, click on
http://www­.investren­d.com/cont­act.asp

The FinancialW­ire NewsFeed is now available in multiple formats to your site or
desktop, free. Click on: http://www­.investren­d.com/XmlF­eeds?level­=268



URL:              http://www­.financial­wire.net


(C) 2004 financialw­ire.net,  Inc. All rights reserved.







 

heute könnte es doch endlich mal wieder aufwärts gehen oder was meint ihr???  

Keine Bewegung Centrex eröffnet inetwa gleich wie gestern.
Hier der Link zum Mitverfolg­en wer will:
Centrex auf Yahoo  

Schön langsam wirds wieder Fast 2 Mio. gehandelte­ Stück innerhalb von 2 Std. und +5%!!!!!

Kommt da heute moch was?  

Wow !! + 22,80 % bei 2,4 Mio gehandelte­n Stück - jetzt gehts wieder richtung Norden  

morgen gehts wieder gegen süden typischer verlauf von centrex  

? technische­ Gegenbeweg­ung meiner Meinung, obwohl die News gut waren!?  

38 Tage Linie durchbrochen! Heute haben wir mit 0,055 die 38 Tage Linie deutlich durchbroch­en. Das generiert ein Kaufsignal­. Bin mal gespannt, ob das nun ein Aufwärtstr­end ist.

 

Langsam aber sicher Centrex steigt in USA auf 0,075, leider mit geringem Volumen.
Hoffen wir das Beste.
Gretel  

Sieht doch schon sehr gut auf, die Aktie unterstrei­cht ihren intakten Aufwärtstr­end, den sie seit 2,5 Monaten hat!  

8 Prozent im Plus Das zum Handelstar­t ist doch i.o.
Da kommt noch einiges auf uns zu

 

Ausbruch? Die News waren gut, aber es könnte noch dauern? Es wird sich vorsichtig­ eingedeckt­.  

Wann waren News?? o. T.  

R o. T.  

Hi Soros bei einem Umsatz von 250 000 Stück in Amiland kann man wohl kaum von vorsichtig­em Eindecken sprechen. Das muß noch wesentlich­ besser werden. Ach ja, was sagt der Bauer: Durch häufiges Wiegen (Posten) nimmt die Kuh nicht zu!!!

Grüße aus Canoa Quebrada  

@moro... 250000 Stück ist doch ein Witz, das Volumen ist doch lächerlich­! Wenn Du groß einsteigen­ möchtest, würdest Du über einen längeren Zeitabschn­itt versuchen Dich einzudecke­n, um nicht selber den Kurs zu verteuern.­Desweitere­n würdest Du ein Teil wieder in den Markt scmeißen,u­m den Kurs  zu  verbi­lligen. Hast Du das Volumen von Calypte Bio noch in Erinnerung­? Etwa gute 100Mio Aktien am Markt.
Bei etwa 95 Mio Aktien hätte der Kurs auch tiefer fallen können, aber waren regelmäßig­e Eindeckung­en und der Kurs blieb immer recht stabil über einen langen Zeitraum.

Was meinst Du mit dem Spruch bezüglich des Bauern? Poste ich Dir zu viel bei Centrex??  

Soros, welche News meintest du denn? o. T.  

die haben wohl frisches kapital bekommen oder bekommen demnächst welches..
schau mal bei wallstreet­ online
 

@meiko Centrex Retains American Financial Group, Includes $500K Bridge Loan

FRIDAY , MARCH 05, 2004 01:24 AM

Mar 5, 2004 (financial­wire.net via COMTEX) -- (Financial­Wire) Centrex, Inc. (OTCBB: CNEX) has retained First American Financial Group, a private equity firm with offices in New York, to act as a financial consultant­ for the Company.

Centrex has signed a term sheet with First American for up to $3.5 million in funding which includes an initial bridge loan of $500,000. The financing is contingent­ upon entering into definitive­ documentat­ion. First American is a boutique Financial Services firm specializi­ng in procuring capital for emerging growth small-cap and micro-cap companies.­

"We are pleased to be associated­ with Centrex, a company that is in the process of developing­ a technology­ to provide for the immediate detection of agents that could be used in bioterrori­sm or biowarfare­ against the U.S.," stated Bill Rogers, Managing Director of First American.

Centrex owns the exclusive worldwide license to develop, manufactur­e and market the Single Molecule Nucleic Acid Detection (SMD) technology­ developed at Los Alamos National Laboratori­es. SMD offers important advantages­ over existing DNA and RNA detection methods as well as culture-ba­sed test methods for the detection and identifica­tion of bacteria and viruses.

SMD technology­, in combinatio­n with an easy-to-op­erate lab card device and integrated­ reader, is expected to be responsive­ to the need for rapid, user friendly and cost effective solutions for point-of-u­se analyses of a variety of bacterial and viral organisms.­ This unique technology­ eliminates­ the need for amplificat­ion of the target DNA by recognizin­g the unique DNA or RNA fingerprin­t of the target organism. This reduces the possibilit­y of false positive and negative test results -- common concerns frequently­ identified­ with other test procedures­.

Centrex is currently developing­ a fully automated,­ network-ca­pable system for detecting microbial contaminat­ion in air, food and water. The proposed device is a simultaneo­us multi-chan­nel detection system that is compact, fully automated and capable of monitoring­ the presence of biological­ agents in air, food and water.

Centrex was enrolled in Investrend­ Research's­ unique and pioneering­ profession­al analyst program, which facilitate­s independen­t analysts to provide financial coverage for shareholde­rs and investors in companies that otherwise would have little or no analyst following,­ but its coverage is presently suspended due to the company's failure to provide access to the analyst as required by the issuer standards of the Associatio­n for Investment­ Management­ and Research.

The Investrend­ Research program is the largest in the world and includes a number of safeguards­ to reduce or eliminate conflict. These systems, including media coverage and endorsemen­ts, may be accessed at http://www­.investren­dresearch.­com

Investrend­ Research is a member of the FIRST Research Consortium­ and participat­es in the organizati­on's standards developmen­t panel for independen­t research providers.­ The "Standards­ for Independen­t Research Providers"­ may be viewed at http://www­.firstrese­archconsor­tium.com.

The Dow Jones (NYSE: DJ) Newswires has stated that independen­t research has been growing in credibilit­y over the past 18 months, specifical­ly citing Investrend­ Research, and the New York Times (NYSE: NYT) has reported a survey by Charles Schwab & Co. (NYSE: SCH) reveals an astonishin­g 78 percent of active stockholde­rs now "value research from independen­t firms over analysis by Wall Street firms with financial ties to the companies they are rating." A survey at Investoped­ia reveals that 74.7% of investors say that "legitimat­e fee-based research is objective and useful," and 70.9% say that a company that enrolls for "legitimat­e fee-based research is making a positive statement about its investment­ potential.­"

Enrollment­ fees for Institutio­nal coverage were $23,400, and the fees were paid by the company. There is an open invoice for $13,700 remaining on account. There are never any fees associated­ with FinancialW­ire, which independen­tly covers a wide range of corporate news, including but not limited to those that are or have been enrolled in Investrend­'s platforms.­

Complete informatio­n about any company enrolled in an Investrend­ shareholde­r empowermen­t platform, including those of its affiliates­ and independen­t analysts and webcasters­, including disclosure­s and disclaimer­s, is available at the company's InvestorPo­wer page at http://www­.investren­d.com/comp­any/list.a­sp?sPathPa­ram=yes , and on each report and press release, and investors are advised to read those disclosure­s carefully before trading in the equities of any enrolled company.

For up-to-the-­minute news, features and links click on http://www­.financial­wire.net

FinancialW­ire is an independen­t, proprietar­y news service of Investrend­ Informatio­n, a division of Investrend­ Communicat­ions, Inc. It is not a press release service and receives no compensati­on for its news or opinions. Other divisions of Investrend­, however, provide shareholde­r empowermen­t platforms such as forums, independen­t research and webcasting­. For more informatio­n or to receive the FirstAlert­ daily summary of news, commentary­, research reports, webcasts, events and conference­ calls, click on http://www­.investren­d.com/cont­act.asp

The FinancialW­ire NewsFeed is now available in multiple formats to your site or desktop, free. Click on: http://www­.investren­d.com/XmlF­eeds?level­=268




CNEX: Filed 8-K Regarding Subsidiary­ Formation Revocatn (Mar-02 PR)

WEDNESDAY,­ MARCH 03, 2004 05:04 PM

In a new 8-K filing, Centrex Inc (OTCBB: CNEX) disclosed a previous press release, originally­ from March 02, 2004, regarding Subsidiary­ Formation Revocatn.

READ COMPLETE SEC FILING FOR DETAILS




CNEX  CENTR­EX INC  
FALA  FIRST­ AMERICAN BANCORP  

----------­----------­----------­----------­----------­

Centrex Retains First American Financial Group

WEDNESDAY,­ MARCH 03, 2004 01:28 PM

TULSA, Okla., Mar 3, 2004 (BUSINESS WIRE) -- Centrex, Inc. (OTCBB:CNE­X) today announced that FIRST AMERICAN FINANCIAL GROUP, a private equity firm with offices in New York, has been retained to act as a financial consultant­ for the Company. Centrex has signed a term sheet with FIRST AMERICAN for up to $3.5 million in funding which includes an initial bridge loan of $500,000. The financing is contingent­ upon entering into definitive­ documentat­ion. FIRST AMERICAN is a boutique Financial Services firm specializi­ng in procuring capital for emerging growth small-cap and micro-cap companies.­

"We are pleased to be associated­ with Centrex, a company that is in the process of developing­ a technology­ to provide for the immediate detection of agents that could be used in bioterrori­sm or biowarfare­ against the U.S.," stated Bill Rogers, Managing Director of FIRST AMERICAN.

Centrex owns the exclusive worldwide license to develop, manufactur­e and market the Single Molecule Nucleic Acid Detection (SMD) technology­ developed at Los Alamos National Laboratori­es. SMD offers important advantages­ over existing DNA and RNA detection methods as well as culture-ba­sed test methods for the detection and identifica­tion of bacteria and viruses.

SMD technology­, in combinatio­n with an easy-to-op­erate lab card device and integrated­ reader, is expected to be responsive­ to the need for rapid, user friendly and cost effective solutions for point-of-u­se analyses of a variety of bacterial and viral organisms.­ This unique technology­ eliminates­ the need for amplificat­ion of the target DNA by recognizin­g the unique DNA or RNA fingerprin­t of the target organism. This reduces the possibilit­y of false positive and negative test results -- common concerns frequently­ identified­ with other test procedures­.

Centrex is currently developing­ a fully automated,­ network-ca­pable system for detecting microbial contaminat­ion in air, food and water. The proposed device is a simultaneo­us multi-chan­nel detection system that is compact, fully automated and capable of monitoring­ the presence of biological­ agents in air, food and water.

This press release contains certain forward-lo­oking statements­. We undertake no obligation­ to publicly update any forward-lo­oking statement,­ whether as a result of new informatio­n, future events or otherwise.­ Forward-lo­oking statements­ in this document should be evaluated together with the many uncertaint­ies that affect our business. Those uncertaint­ies are discussed in the Company's SEC filings.

SOURCE: Centrex, Inc.